1. EP-1088: Is time from symptom to treatment a prognostic factor in stage III-IV head and neck cancer patients?. (April 2016) Authors: Furlan, C.; Polesel, J.; Gobitti, C.; Minatel, E.; Vaccher, E.; Barzan, L.; Grando, G.; Franchin, G. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term update of the 24954 EORTC phase III trial on larynx preservation. (September 2016) Authors: Henriques De Figueiredo, B.; Fortpied, C.; Menis, J.; Lefebvre, J.L.; Barzan, L.; de Raucourt, D.; Geoffrois, L.; Giurgea, L.; Hupperets, P.; Leemans, C.R.; Licitra, L.; Rolland, F.; Tesselaar, M.; Vermorken, J.B.; Grégoire, V. Journal: European journal of cancer Issue: Volume 65(2016) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1107 miR-9 as predictor of response to Radiotherapy and Cetuximab in patients with head and neck cancers. (May 2022) Authors: Fanetti, G.; Musco, L.; Citron, F.; Segatto, I.; Micciché, F.; Turturici, I.; Lupato, V.; Matrone, F.; Giacomarra, V.; Barzan, L.; Franchin, G.; Baldassarre, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗